Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) December 31, 2025
Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer December 15, 2025
